Chemotherapy in hormone-refractory prostate cancer: Docetaxel with and without VT122.

被引:0
|
作者
Bhattacharyya, Gouri Shankar
Bascomb, Newell
Malhotra, Hemant
Biswas, Ghanashyam
Bondarde, Shailesh Arjun
机构
[1] FORTIS Hosp, Kolkata, India
[2] Vicus Therapeut, Morristown, NJ USA
[3] ICON ARO, Jaipur, Rajasthan, India
[4] Sparsh Hosp & Crit Care, Bhubaneswar, India
[5] Shatabdi Super Specialty Hosp, Nasik, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16062
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Significance of docetaxel in the chemotherapy of hormone-refractory prostate cancer
    Wolff, JM
    ONKOLOGIE, 2003, 26 : 37 - 40
  • [2] Docetaxel (Taxotere) in hormone-refractory prostate cancer
    Petrylak, DP
    SEMINARS IN ONCOLOGY, 2000, 27 (02) : 24 - 29
  • [3] Docetaxel and exisulind in hormone-refractory prostate cancer
    Ryan, CW
    Stadler, WM
    Vogelzang, NJ
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 56 - 61
  • [4] Docetaxel in hormone-refractory metastatic prostate cancer
    Oh, WK
    DRUGS, 2005, 65 (16) : 2296 - 2297
  • [5] Docetaxel for hormone-refractory prostate cancer Reply
    Damber, Jan-Erik
    Aus, Gunnar
    LANCET, 2008, 372 (9648): : 1461 - 1462
  • [6] Chemotherapy of the hormone-refractory prostate cancer
    Heine, K
    Wolff, JM
    AKTUELLE UROLOGIE, 2004, 35 (03) : 209 - 214
  • [7] Chemotherapy for hormone-refractory prostate cancer
    Shelley, Mike
    Harrison, Craig
    Coles, Bernadette
    Staffurth, John
    Wilt, Timothy J.
    Mason, Malcolm D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [8] Chemotherapy in hormone-refractory prostate cancer
    de Wit, Ronald
    BJU INTERNATIONAL, 2008, 101 : 11 - 15
  • [9] Chemotherapy in hormone-refractory prostate cancer
    Wolff, Johannes Maria
    CONTROVERSIES IN THE TREATMENT OF PROSTATE CANCER, 2008, 41 : 103 - 107
  • [10] Chemotherapy in hormone-refractory prostate cancer
    Biedermann, B
    Pless, M
    Herrmann, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (28-29) : 874 - 879